AMARYLLIS (Q3989669): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claims)
(‎Changed an Item: Fix Beneficiary from Netherlands)
Property / beneficiary name (string)
 
Maastricht Instruments BV
Property / beneficiary name (string): Maastricht Instruments BV / rank
 
Normal rank
Property / beneficiary
 
Property / beneficiary: Q3987746 / rank
 
Normal rank

Revision as of 09:47, 16 December 2021

Project Q3989669 in Netherlands
Language Label Description Also known as
English
AMARYLLIS
Project Q3989669 in Netherlands

    Statements

    0 references
    514,551.96 Euro
    0 references
    1,475,299.17 Euro
    0 references
    34.878 percent
    0 references
    1 June 2015
    0 references
    31 December 2017
    0 references
    Maastricht Instruments BV
    0 references
    0 references

    50°50'15.07"N, 5°42'29.66"E
    0 references

    50°49'57.32"N, 5°42'54.00"E
    0 references
    6200 MD
    0 references
    6229 EV
    0 references
    6229 EG
    0 references
    6200 MD
    0 references
    Een laagdrempelig platform voor de productie van een veilig, laagimmunogeen stamcel preparaat. (Dutch)
    0 references
    A low-threshold platform for the production of a safe, low-immune stem cell preparation. (English)
    15 December 2021
    0 references
    Une plate-forme à seuil bas pour la production d’une préparation sûre de cellules souches à faible taux d’immune. (French)
    15 December 2021
    0 references
    Eine niedrigschwellige Plattform für die Herstellung einer sicheren, niedrigimmunen Stammzellpräparation. (German)
    15 December 2021
    0 references

    Identifiers

    OP-2014-2023-Zuid-PROJ-00009
    0 references